{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:59:45Z","timestamp":1770040785706,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.micpath.2020.104389","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T11:52:04Z","timestamp":1595332324000},"page":"104389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model"],"prefix":"10.1016","volume":"147","author":[{"given":"Wanhe","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuiyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunahu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.micpath.2020.104389_bib1","first-page":"1126","article-title":"Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States","volume":"14","author":"LoBue","year":"2010","journal-title":"Int. J. Tuberc. Lung. Dis."},{"issue":"10","key":"10.1016\/j.micpath.2020.104389_bib2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1462-5822.2010.01511.x","article-title":"Dynamics of growth and dissemination of Salmonella in vivo","volume":"12","author":"Watson","year":"2010","journal-title":"Cell Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2020.104389_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2958.2004.04017.x","article-title":"Adaptation of the brucellae to their intracellular niche","volume":"52","author":"Roop","year":"2004","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2020.104389_bib4","first-page":"3281","article-title":"Nanomedicine as an emerging approach against intracellular pathogens","volume":"6","author":"Armstead","year":"2011","journal-title":"Int. J. Nanomedicine."},{"issue":"1","key":"10.1016\/j.micpath.2020.104389_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4142\/jvs.2000.1.1.33","article-title":"Detection of Lawsonia intracellularis in diagnostic specimens by one-step PCR","volume":"1","author":"Suh","year":"2000","journal-title":"J. Vet. Sci."},{"issue":"6","key":"10.1016\/j.micpath.2020.104389_bib6","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/j.1365-2672.2009.04389.x","article-title":"Quantification of Lawsonia intracellularis in porcine faeces by real-time PCR","volume":"107","author":"Nathues","year":"2009","journal-title":"J. Appl. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2020.104389_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2885.1998.00133.x","article-title":"Intracellular accumulation, subcellular distribution and efflux of tilmicosin in swine phagocytes","volume":"21","author":"Scomeaux","year":"1998","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.micpath.2020.104389_bib8","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/jcm.33.5.1314-1317.1995","article-title":"Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy","volume":"33","author":"Mcorist","year":"1995","journal-title":"J. Clin. Microbiol."},{"issue":"3\u20134","key":"10.1016\/j.micpath.2020.104389_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.vetmic.2008.08.007","article-title":"In vitro antimicrobial activity against 10 North American and European Lawsonia intracellularis isolates","volume":"134","author":"Wattanaphansak","year":"2009","journal-title":"Vet. Microbiol."},{"issue":"9","key":"10.1016\/j.micpath.2020.104389_bib10","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1128\/AAC.00408-11","article-title":"Antimicrobial susceptibility testing of two Lawsonia intracellularis isolates associated with proliferative hemorrhagic enteropathy and porcine intestinal adenomatosis in South Korea","volume":"55","author":"Yeh","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.micpath.2020.104389_bib11","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.4142\/jvs.2019.20.e40","article-title":"Pharmacokinetics\/Pharmacodynamics models of veterinary antimicrobial agents","volume":"20","author":"Luo","year":"2019","journal-title":"J. Vet. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2020.104389_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1099\/jmm.0.045971-0","article-title":"Evaluation of antimicrobial activity against Mycoplasma mycoides subsp. mycoides Small Colony using an in vitro dynamic dilution pharmacokinetic\/pharmacodynamic model","volume":"62","author":"Mitchell","year":"2013","journal-title":"J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2020.104389_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jiac.2015.02.001","article-title":"Applications of the pharmacokinetic\/pharmacodynamic (PK-PD) analysis of antimicrobial agents","volume":"21","author":"As\u00edn-Prieto","year":"2015","journal-title":"J. Infect. Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2020.104389_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7774\/cevr.2013.2.2.135","article-title":"Efficacy of a commercial live attenuated Lawsonia intracellularis vaccine in a large scale field trial in Korea","volume":"2","author":"Park","year":"2013","journal-title":"Clin. Exp.Vaccine. Res."},{"issue":"3\u20134","key":"10.1016\/j.micpath.2020.104389_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.vetmic.2004.09.015","article-title":"Infection dynamics of Lawsonia intracellularis in pig herds","volume":"104","author":"Stege","year":"2004","journal-title":"Vet. Microbiol."},{"issue":"3\u20134","key":"10.1016\/j.micpath.2020.104389_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.vetmic.2004.04.014","article-title":"Routine diagnostics of Lawsonia intracellularis performed by PCR, serological and post mortem examination, with special emphasis on sample preparation methods for PCR","volume":"102","author":"Jacobson","year":"2004","journal-title":"Vet. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2020.104389_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcpa.2006.08.006","article-title":"Distinction between Porcine circovirus type 2 enteritis and porcine proliferative enteropathy caused by Lawsonia intracellularis","volume":"135","author":"Jensen","year":"2006","journal-title":"J. Comp. Pathol."},{"issue":"6","key":"10.1016\/j.micpath.2020.104389_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/104063870001200608","article-title":"In vitro susceptibility of porcine respiratory pathogens to tilmicosin","volume":"12","author":"DeRosa","year":"2000","journal-title":"J. Vet. Diagn. Invest."},{"issue":"26","key":"10.1016\/j.micpath.2020.104389_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/vr.146.26.745","article-title":"Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against recent field isolates of Mycoplasma bovis","volume":"146","author":"Ayling","year":"2000","journal-title":"Vet. Rec."},{"key":"10.1016\/j.micpath.2020.104389_bib20","first-page":"385","article-title":"The epidemiologic and pharmacodynamic cutoff values of tilmicosin against Haemophilus parasuis","volume":"7","author":"Peng","year":"2016","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2020.104389_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4142\/jvs.2017.18.4.431","article-title":"Pharmacokinetics of tilmicosin in healthy pigs and in pigs experimentally infected with Haemophilus parasuis","volume":"18","author":"Zhang","year":"2017","journal-title":"J. Vet. Sci."},{"issue":"5","key":"10.1016\/j.micpath.2020.104389_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/00480169.2019.1633434","article-title":"Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with Actinobacillus pleuropneumoniae","volume":"67","author":"Xiong","year":"2019","journal-title":"N. Z. Vet. J."},{"issue":"4","key":"10.1016\/j.micpath.2020.104389_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0924-8579(02)00022-5","article-title":"Animal model pharmacokinetics and pharmacodynamics: a critical review","volume":"19","author":"Andes","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2020.104389_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.anaerobe.2016.04.005","article-title":"Ex vivo pharmacokinetic\/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits","volume":"39","author":"Zhou","year":"2016","journal-title":"Anaerobe"},{"issue":"1","key":"10.1016\/j.micpath.2020.104389_bib25","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1038\/s41598-017-03970-9","article-title":"Pharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine","volume":"7","author":"Yan","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.micpath.2020.104389_bib26","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/jac\/dkr214","article-title":"The 2010 Garrod Lecture: the dimensions of evolution in antibiotic resistance: ex unibus plurum et ex pluribus unum","volume":"66","author":"Baquero","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/j.micpath.2020.104389_bib27","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1128\/AAC.00670-13","article-title":"Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut microbiota","volume":"57","author":"Zhang","year":"2013","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020307555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020307555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:36:36Z","timestamp":1760110596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401020307555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":27,"alternative-id":["S0882401020307555"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104389","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104389"}}